Author/Authors :
Sezavar, Hashem Associate Professor of Cardiology - Rasoul-e-Akram Hospital - Tehran University of Medical Sciences , Farahani, Behzad Associate Professor of Cardiology - Frioozgar Hospital - Tehran University of Medical Sciences, Tehran , Gholami, Saeid Firoozgar Hospital clinical research development center - Tehran University of Medical Sciences, Tehran , Moradi, Masoud Medical Student - Tehran University of Medical Sciences, Tehran , Zarei, Mina General practitioner - Tehran University of Medical Sciences, Tehran , Ganji, Morsaleh General practitioner - Tehran University of Medical Sciences, Tehran , miri, Shahnaz Students Scientific Research Center - Tehran University of Medical Sciences, Tehran , Khalili, Neda General practitioner - Tehran University of Medical Sciences, Tehran , Jafarian Kerman, Scott Reza Students Scientific Research Center - Tehran University of Medical Sciences, Tehran
Abstract :
Myocardial infarction (MI) is one of the most important health burdens worldwide. Aspirin as an non- Steroid Anti—inflammatory drug, has been proven to be a protective factor to decrease the incidence, however its effect of MI size is still unknown. We designed this study to compare the biomarkers after MI in patients with and without aspirin intake. 378 patients were enrolled and the results showed lower
cardiac troponin T and Creatine Kinases in patients with protective dose of aspirin intake. In addition, Creatine Kinases were significantly higher in patients with no history of MI. We conclude that aspirin can reduce the size of the infraction. Also, higher enzymes can be due to higher muscle content in patient without MI history.
Keywords :
Aspirin , Myocardial infarction size , Troponin T , Creatine Kinase
